CTOs on the Move


 
Amway is the world`s No. 1 direct selling business, according to the Direct Selling News Global 100. Established in 1959, with sales of $8.6 billion, Amway operates in more than 100 countries and territories. We manufacture and distribute 450+ consumer products that support health and well-being. More than 19,000 employees worldwide support millions of Amway Business Owners who sell Amway products. Headquartered in Ada, Michigan, Amway is a center of health, skincare and home product innovation and top-selling, global brands. In addition, we are a company committed to providing employees with challenging career opportunities, a comprehensive total rewards package, profit ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.amway.com
  • 7575 Fulton Street East
    Ada, MI USA 49355
  • Phone: 616.787.1000

Executives

Name Title Contact Details
Ali Syed
VP Information Security and Risk (CISO) Profile

Similar Companies

Memorial Hospital of Rhode Island

Memorial Hospital of Rhode Island is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Memorial Hospital of Rhode Island is based in Pawtucket, RI. You can find more information on Memorial Hospital of Rhode Island at www.mhri.org

Healthcare Strategy Institute

Healthcare Strategy Institute, Inc. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metro Record Svc

Metro Record Svc is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cohera Medical

Cohera Medical, Inc. is a rapidly growing medical device company actively developing surgical adhesives and sealants. TissuGlu Surgical Adhesive, the first synthetic adhesive approved for internal use, is an easily applied biocompatible, resorbable adhesive that requires no mixing or thawing. Indicated for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty, TissuGlu Surgical Adhesive has been shown to eliminate the need for postoperative surgical drains in most abdominoplasty procedures.

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.